Movement Disorder Society (MDS)
26^th International Congress of Parkinson's Disease and Movement Disorders in Madrid, Spain (Sept. 15-18, 2022)

• Racial differences in essential tremor.
  

  Jamal F, Noorbhai I, Jackson G, Sarwar A

• Chronotype and cognition in veterans with Parkinson's disease.
  

  Sarwar A

Movement Disorder Society (MDS)
Virtual International Congress of Parkinson's Disease and Movement Disorders. (Sept. 17-22, 2021)

• Deep brain stimulation surgery and clinical characteristics of essential tremor in a cohort of veterans.
  

  Noorbhai IZ, Jamal F, Jackson G, Sarwar A

American Academy of Neurology (AAN)
Virtual 2021 Annual Meeting (April 17-22, 2021)

• Age of onset and deep brain stimulation in a cohort of essential tremor.
  

  Jamal F, Sarwar A

• Ten year clinical outcomes of subthalamic nucleus versus pallidal deep brain stimulation for Parkinson's disease: VA/NINDS CSP #468F.
  

  Ostrem J, Luo P, Weaver F, Follett K, Galifianakis N, Lai E, et al.

Movement Disorder Society (MDS)
Virtual International Congress of Parkinson's Disease and Movement Disorders. (Sept. 12-16, 2020)

• Is chronotype a biomarker for depression in military veterans with Parkinson's disease?
  

  Sarwar A

• Use of botulinum toxin: Experience in a cohort of essential tremor patients.
  

  Shah C, Jamal F, Sarwar A, Jackson G

American Academy of Neurology (AAN)
72^nd Annual Meeting in Toronto, Ontario, Canada (April 25 - May 1, 2020)

• Treatment patterns in patients with essential tremor.
  

  Shah C, Jamal F, Jackson G, Sarwar A

Movement Disorder Society (MDS)
23^rd International Congress of Parkinson's Disease and Movement Disorders in Nice, France (Sept. 22-26, 2019)

• Age of onset and diagnosis of essential tremor.
  

  Jamal F, Jackson GR, Moore S, Sarwar AI

• Is sleep disordered breathing a risk factor for REM sleep behavior disorder in military Veterans with Parkinson's disease?
  

  Sarwar AI, Moore S

American Academy of Neurology (AAN)
71^st Annual Meeting in Philadelphia, Penn. (May 4-10, 2019)

• Vitamin D assessment in veterans with Parkinson's disease.
  

  Jamal F, Jackson GR, Moore S, Sarwar A

Movement Disorder Society (MDS)
22^nd International Congress of Parkinson's Disease and Movement Disorders in Hong Kong, China (Oct. 5-9, 2018)

• Is REM sleep behavior disorder associated with excessive daytime sleepiness in military veterans with Parkinson's disease?
  

  Sarwar A, Moore S

American Academy of Neurology (AAN)
70^th Annual Meeting in Los Angeles, Calif. (April 21-27, 2018)

• Is excessive daytime sleepiness related to nocturnal sleep in Parkinson's disease?
  

  Sarwar A, Moore S, Hirshkowitz M

Movement Disorder Society (MDS)
21^st International Congress of Parkinson's Disease and Movement Disorders in Vancouver, BC, Canada (June 4-8, 2017)

• Predictive ability of clinical timed tests for postural instability and gait difficulty in Parkinson's disease.
  

  Bryant M, Hou J-G, Jamal F, Jackson G, Workman C, Protas E

• Vitamin D and clinical phenotypes of Parkinson's disease in veterans.
  

  Jamal F, Jackson GR, Moore S, Sarwar AI

American Academy of Neurology (AAN)
69^th Annual Meeting in Boston, Mass. (April 22-28, 2017)

• Leg discomfort and insomnia in Parkinson's disease.
  

  Sarwar A, Moore S, Hirshkowitz M

Society for Neuroscience (SFN)
46^th Annual Meeting in San Diego, Calif. (Nov. 12-16, 2016)

• Effects of tau peptide aggregation inhibitor in human tau transgenic models.
  

  Frautschy SA, Hu S, Jones MR, Yang F, Chen P, Jackson GR, et al.

American Academy of Neurology (AAN)
68^th Annual Meeting in Vancouver, BC, Canada (April 15-21, 2016)

• Chronotypes, nocturnal melatonin level and excessive daytime sleepiness in Parkinson's disease (PD).
  

  Sarwar A, Moore S, Hirshkowitz M

American Neurological Association (ANA)
140^th Annual Meeting in Chicago, Ill. (Sept. 27-29, 2015)

• Safety of treadmill exercise testing in Parkinson disease.
  

  Jackson GR, Bryant M, Zaheer F, Protas E

Movement Disorder Society (MDS)
19^th International Congress of Parkinson's Disease and Movement Disorders in San Diego, Calif. (June 14-18, 2015)

• Gait and balance in Parkinson's disease (PD) following bilateral Subthalamic Nucleus (STN) and Globus Pallidus Interna (GPi) stimulation: 36 month follow-up of CSP#468 cohort.
  

  Sarwar AI, Carlson K, Luo P, Follett KA, Stern M, Weaver FM, et al.

American Academy of Neurology (AAN)
67^th Annual Meeting in Washington, DC (April 18-25, 2015)

• Hemichorea in a patient with diabetic ketoacidosis.
  

  Yassin A, Shroff S, Patel S, Parker A, Berman M, Jackson G

Movement Disorder Society (MDS)
18^th International Congress of Parkinson's Disease and Movement Disorders in Stockholm, Sweden (June 8-12, 2014)

• Impact of post traumatic stress disorder (PTSD) on the clinical expression of REM sleep behavior disorder (RBD) in veterans with Parkinson's disease (PD).
  

  Sarwar AI, Moore S, Hirshkowitz M

• Parkinson's disease and ocular melanoma in veterans.
  

  Zaheer F, Moore S, Sarwar AI

American Academy of Neurology (AAN)
66^th Annual Meeting in Philadelphia, Penn. (April 26 - May 3, 2014)

• Zung Self Rating Depression Scale in Parkinson's disease: A validity study in veterans.
  

  Sarwar A, Hirshkowitz M

Movement Disorder Society (MDS)
17^th International Congress of Parkinson's Disease and Movement Disorders in Sydney, Australia (June 16-20, 2013)

• Long-term outcomes from the VA/NIH Cooperative Study on deep brain stimulation for Parkinson's disease.
  

  Marks Jr W, Luo P, Lanier E, Patel U, Carlson K, Rothlind J, et al.

• Sleep disordered breathing and excessive sleepiness in Parkinson's disease.
  

  Sarwar AI, Sarwar O, Hirshkowitz M

American Academy of Neurology (AAN)
65^th Annual Meeting in San Diego, Calif. (March 16-23, 2013)

• Parkinson's disease and narcolepsy.
  

  Sarwar A, Hirshkowitz M

Keystone Symposium
New Frontiers in Neurodegenerative Disease Research Meeting in Santa Fe, N.M. (Feb. 5, 2013)

• Casein kinase Iε phosphorylation of TDP-43 causes oligomerization and enhances toxicity in vivo.
  

  Jackson GR, Choksi DK, Roy B, Chatterjee S, Sengupta E, Kayed R

Movement Disorder Society (MDS)
16^th International Congress of Parkinson's Disease and Movement Disorders in Dublin, Ireland (June 17-21, 2012)

• Pathological sleepiness and age in Parkinson's disease.
  

  Sarwar AI, Hirshkowitz M

American Academy of Neurology (AAN)
64^th Annual Meeting in New Orleans, La. (April 21-28, 2012)

• Comparing clinical features of young-onset, middle-onset and late-onset Parkinson's disease.
  

  Mehanna R, Moore S, Hou J-G, Lai E, Sarwar A

• Excessive sleepiness and depression in Parkinson's disease.
  

  Sarwar A, Hirshkowitz M

Biochemical Society
Conference: The biology and pathology of tau and its role in tauopathies II in Cambridge, U.K. (Jan. 8-9, 2012)

• Dissection of tauopathy mechanisms using unbiased genetic screening in the Drosophila retina.
  [Invited Plenary Speaker]
  

  Jackson GR

Society for Neuroscience (SFN)
41^st Annual Meeting in Washington, DC (Nov. 12-16, 2011)

• Blue cheese/Alfy affects autophagy activation and tau toxicity in a Drosophila model of tauopathy.
  

  Bakhoum MF, Jackson GR

• RNA binding protein hnRNP K/bancal and its intronic microRNA miR-7 exert opposite effects on tau toxicity through regulation of Insulin Receptor Substrate/chico and GSK-3beta activity.
  

  Jackson GR, Ambegaokar S

American Neurological Association (ANA)
136^th Annual Meeting in San Diego, Calif. (Sept. 25-27, 2011)

• Comparison of subthalamic (STN) and pallidal (GPI) deep brain stimulation (DBS) on gait and balance in patients with Parkinson's disease (PD).
  

  Hou JG, Thant M, Sarwar A, Fincher L, Bryant MS, Atassi F, et al.

Movement Disorder Society (MDS)
15^th International Congress of Parkinson's Disease and Movement Disorders in Toronto, Canada (June 5-9, 2011)

• Situational sleep tendency in "sleepy" veterans with Parkinson's disease.
  

  Sarwar AI, Varghese R, Lai EC

American Academy of Neurology (AAN)
63^rd Annual Meeting in Honolulu, Hawaii (April 9-16, 2011)

• Levodopa is necessary to improve gait and balance in Parkinson's patients after deep brain stimulator implantation.
  

  Hou JG, Thant M, Bryant MS, Fincher L, Sarwar A, Lai E

• Chronotypes in Parkinson's disease: What are they? And what can they predict?
  

  Sarwar AI, Varghese R, Hirshkowitz M, Lai EC, Johnson S, Hou JG

2010 American Society for Cell Biology (ASCB)
Annual Meeting in Philadelphia, Penn. (Dec. 11-15, 2010)

• An unbiased genetic screen for modifiers of tauopathy using both loss and gain of function approaches.
  

  Jackson GR, Ambegaokar S

Society for Neuroscience (SFN)
40^th Annual Meeting in San Diego, Calif. (Nov. 13-17, 2010)

• Modulation of tau oligomers by passive vaccination.
  

  Castillo DL, Lasagna-Reeves C, Guerrero-Munoz MJ, Estes DM, Barrett A, Dineley K, et al.

• Characterization of tau oligomers in Alzheimer's disease.
  

  Kayed R, Lasagna-Reeves C, Guerrero-Munoz M, Sengupta U, Troncoso J, Jackson GR

• Synergistic effects of tau and alpha-synuclein in dopaminergic neurons.
  

  Roy B, Ambegaokar SS, Jackson GR

• Tau oligomers in Parkinson disease and dementia with Lewy bodies and their connection with alpha-synuclein oligomers.
  

  Sengupta U, Lasagna-Reeves C, Guerrero-Munoz M, Castillo-Carranza D, Jackson GR, Troncoso J, et al.

Movement Disorder Society (MDS)
14^th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina (June 13-17, 2010)

• Alpha-synuclein oligomers in Parkinson's disease and Lewy body dementia.
  

  Castillo-Carranza DL, Lasagna-Reeves CA, Guerrero-Munoz MJ, Roy B, Jackson GR, Kayed R

• The formation of pore-like amyloid aggregates in movement disorders.
  

  Lasagna-Reeves CA, Jackson GR, Troncoso J, Kayed R

• Role of tau oligomers in Parkinson's disease and dementia with Lewy bodies.
  

  Lasagna-Reeves CA, Roy B, Bakhoum M, Guerrero-Munoz MJ, Castillo-Carranza DL, Troncoso J, et al.

• Handedness and Parkinson's disease.
  

  Sarwar AI, Lai EC

NINDS and ALS Association
Workshop: Advances in Disease Modeling for ALS and FTD in San Diego, Calif. (2010)

• Wing phenotypes produced by misexpression of an ALS-associated TDP-43 mutation include supernumerary veins: A possible clue to signaling pathways.
  

  Ambegaokar SS, Yusuff T, Choksi DK, Kayed R, Jackson GR

World Federation of Neurology (WFN)
XVIII World Congress on Parkinson's Disease and Related Disorders in Miami Beach, Fla. (Dec. 13-16, 2009)

• Axial symptoms and basal ganglia in Parkinson's disease. Does side matter?
  

  Sarwar A, Lai EC

Movement Disorder Society (MDS)
13^th International Congress of Parkinson's Disease and Movement Disorders in Paris, France (June 7-11, 2009)

• Parkinson's disease — Characteristics of disease onset in a veteran population.
  

  Sarwar AI, Lai EC

Movement Disorder Society (MDS)
12^th International Congress of Parkinson's Disease and Movement Disorders in Chicago, Ill. (June 22-26, 2008)

• Association between laterality (right or left) of onset of motor symptoms and degree of speech impairment in veterans with Parkinson's disease (PD).
  

  Sarwar AI, Lai EC

• Deep brain stimulation (DBS) parameters and gait in Parkinson's disease (PD).
  

  Sarwar AI, Lai EC